⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of La Jolla Institute for Immunology and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
La Jolla Institute for Immunology
↗La Jolla, United States
The La Jolla Institute for Immunology (LJI) is a world-renowned, independent, non-profit research organization dedicated exclusively to understanding the immune system. LJI researchers focus on unraveling the complexities of immune responses to develop new treatments and vaccines for autoimmune diseases, cancer, infectious diseases, and neurodegenerative conditions.
Operating as a collaborative hub, the institute hosts national databases, including the Immune Epitope Database (IEDB), and maintains a highly agile research environment. LJI actively translates fundamental scientific discoveries into clinical applications through partnerships with pharmaceutical companies, licensing of over 300 technologies, and sponsored research collaborations.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Founded:1988
Ownership:nonprofit
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical
Modalities:Vaccines, Monoclonal antibodies, Cell therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Kyowa Kirin (long-term research alliance), UC San Diego Health System (affiliation), Global Autoimmune Institute (GAI)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Erica Ollmann Saphire - President and CEO
Shane Crotty - Chief Scientific Officer
Scientific Founders:Makoto Nonaka, Kimishige Ishizaka
LINKS
Website:lji.org
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with La Jolla Institute for Immunology. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.